Literature Cited
L. M. Bershtein, Vopr. Onkol., No. 8, 87 (1982).
V. M. Dil'man, Endocrinologic Oncology [in Russian], Leningrad (1983).
T. S. Saatov, Ukr. Biokhim. Zh., No. 2, 44 (1981).
V. A. Tkachuk and G. N. Baldenkov, Biokhimiya, No. 6, 1097 (1978).
N. A. Fedorov, Biological and Clinical Importance of Cyclic Nucleotides [in Russian], Moscow (1979).
H. P. Bär and J. F. Henderson, Can. J. Biochem.,50, 1003 (1972).
D. E. Brenneman, R. McGee, and A. A. Spector, Cancer Res.,34, 2605 (1974).
J. D. Brown, J. Beerends, and D. C. Bartels, Endocrinology,93, 445 (1973).
W. E. Criss and F. Murad, in: Clinical Aspects of Cyclic Nucleotides, ed. L. Volicer, New York (1977), pp. 429–448.
M. E. Dempsey, Ann. N. Y. Acad. Sci.,148, 631 (1968).
M. D. Houslay and L. M. Gordon, in: Current Topics in Membranes and Transport, Vol. 18, New York (1983), pp. 143–178.
H. Kather, G. Simon-Crisan, and B. Vogt, Horm. Metab. Res.,9, 300 (1977).
D. C. Lehotay, H. S. Paul, J. S. Sindler, et al., Metabolism,32, 157 (1983).
V. Pezzino, V. Trischitta, F. Purrello, et al., Diabetologia,23, 131 (1982).
V. E. Vaskowsky and V. I. Svetashev, J. Chromatogr.,65, 451 (1972).
Rights and permissions
About this article
Cite this article
Bershtein, L.M., Kovaleva, I.G. & Rozenberg, O.A. Effect of hypolipidemic drugs on basal and stimulated adenylate cyclase activity in tumor cells. Bull Exp Biol Med 100, 1243–1245 (1985). https://doi.org/10.1007/BF00839425
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00839425